Andreas Hadjisavvas, PhD, is an expert in molecular genetics. He holds a scientist position in the Department of Electron Microscopy/Molecular Pathology at the Cyprus Institute of Neurology and Genetics (CING). He has been employed at CING since 1995 and was instrumental in establishing the Molecular Pathology laboratory. Dr. Hadjisavvas studies molecular genetics as a tool for cancer risk assessment. He has also used molecular genetics to study molecular mechanisms of complex diseases such as Parkinson's disease (PD). In 2017, he was appointed an associate professor at the Cyprus School of Molecular Medicine. He actively contributed to the organization of a national network of specialists in breast cancer diagnostics and treatment. Dr. Hadjisavvas has received funding for his research in the fields of cancer epidemiology, pathology and genetics.
Associated Grants
-
Changes in Mitochondrial DNA as Diagnostic and Progression Biomarkers of Parkinson's Disease
2018